Report cover image

Prostate Health Market Report and Forecast 2025-2034

Published Jul 28, 2025
Length 350 Pages
SKU # EMAR20319758

Description

The global prostate health market size was valued at USD 38.10 Billion in 2024, driven by the increasing incidence of prostate cancer across the globe. The market size is anticipated to grow at a CAGR of 9.10% during the forecast period of 2025-2034 to achieve a value of USD 91.03 Billion by 2034.

Prostate Health: Introduction

The prostate is a small, rubbery gland in the male reproductive system. It is located in the pelvis, below the bladder and in front of the rectum. It is about the size of a walnut and weighs about 11 grams. The prostate's primary function is to produce the fluid that nourishes and transports sperm. This fluid, called seminal fluid, mixes with sperm from the testes to make semen. Prostate's muscles also help push semen through the urethra.

Prostate health refers to the well-being and proper functioning of the prostate gland, which is a small, walnut-sized organ located just below the bladder in men. The prostate gland plays a crucial role in the male reproductive system by producing seminal fluid, which nourishes and transports sperm during ejaculation.

Global Prostate Health Market Analysis

The growth of the global market for prostate health is driven by the increasing numbers of FDA approvals for new drugs targeted at addressing various aspects of prostate health. For example, approval of the fixed-dose combination of niraparib and abiraterone acetate for patients with certain types of prostate cancer, offering new treatment options is a major step and hope for new and effective treatment for prostate cancers. The market is also driven by the heavy investments by the leading key players. Increasing investments and funding in prostate health research and treatment innovations are also market trends influencing the global prostate health market growth. Researchers have been exploring novel therapies that show promising results in treating prostate cancer, even in cases where existing treatments have proven ineffective. These innovations bring hope to those patients who are suffering from the disease and offer potential innovation in prostate cancer management. Increasing efforts to reduce harm from prostate cancer screening are also accountable for the market growth.

Additionally, strategic mergers and acquisitions among key players in the healthcare industry are also contributing to the market growth. Collaborative efforts, such as the merger between Pfizer Inc. and Seagen Inc., demonstrate a concerted effort to combat cancer and develop transformative therapies. These partnerships are expected to further propel the prostate health market growth.

Global Prostate Health Market Segmentations

“global prostate health market and forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market by Treatment Type
  • Hormonal Therapy
  • Chemotherapy
  • Surgical Treatments
  
  • Radical Prostatectomy

  •   
  • Orchidectomy

  •   
  • Trans Urethral Resection

  •   
  • Others
    • Other Treatment Types
    Market Breakup by Indications
    • Benign Prostatic Hyperplasia (BPH)
    • Prostatitis
    • Prostate Cancer
    • Others
    Market Breakup by Age Group
    • Adults
    • Geriatrics
    • Others
    Market Breakup by End User
    • Hospitals and Clinics
    • Speciality Clinics
    • Homecare Settings
    • Others
    Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Prostate Health Market Overview

    The growth of global prostate health market growth is driven by several key factors including prostate cancer being the second most common cancer in men worldwide, highlighting the quick need for effective treatments and diagnostics. The growing prevalence of benign prostatic hyperplasia (BPH), a common condition among aging men, further contributes to the market's expansion. The increasing geriatric population acts as a major factor driving the market growth as well. The emergence of new treatment therapies and techniques for prostate cancer holds promise in improving patient outcomes and potential to drive market growth. Rapid growth in the availability of biomarker testing, allowing for early detection and more precise treatment decisions also collectively accountable for the market growth. Investments in research and development, coupled with a surge in upcoming pipeline medicines and the availability of innovative prostate treatments, are propelling the global prostate health market growth.

    Geographically, North America is leading the regional market for prostate health, and it is expected to lead the market for the forecast period as well. The prevalence of prostate diseases, including prostate cancer in the region is also increasing, which is driving the market growth. The increased investment in research and development, the promising pipeline of medicines, and the availability of novel prostate health solutions collectively contribute to the market growth.

    Global Prostate Health Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Abbott
    • Novartis AG
    • Teleflex
    • AstraZeneca PLC
    • Bayer AG
    • Sanofi
    • Pfizer
    • Clovis Oncology
    • Siemens Healthcare GmbH
    • Elekta
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Prostate Health Market Overview
    3.1 Global Prostate Health Market Historical Value (2018-2024)
    3.2 Global Prostate Health Market Forecast Value (2025-2034)
    4 Global Prostate Health Market Landscape
    4.1 Global Prostate Health Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Prostate Health Product Landscape
    4.2.1 Analysis by Treatment
    4.2.2 Analysis by Indications
    4.2.3 Analysis by Age Group
    5 Global Prostate Health Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Prostate Health Market Segmentation
    6.1 Global Prostate Health Market by Treatment Type
    6.1.1 Market Overview
    6.1.2 Hormonal Therapy
    6.1.3 Chemotherapy
    6.1.4 Surgical Treatments
    6.1.4.1 Radical Prostatectomy
    6.1.4.2 Orchidectomy
    6.1.4.3 Trans Urethral Resection
    6.1.4.4 Others
    6.1.5 Other Treatment Types
    6.2 Global Prostate Health Market by Indications
    6.2.1 Market Overview
    6.2.2 Benign Prostatic Hyperplasia (BPH)
    6.2.3 Prostatitis
    6.2.4 Prostate Cancer
    6.2.5 Others
    6.3 Global Prostate Health Market by Age Group
    6.3.1 Market Overview
    6.3.2 Adults
    6.3.3 Geriatrics
    6.3.4 Others
    6.4 Global Prostate Health Market by End User
    6.4.1 Market Overview
    6.4.2 Hospitals and Clinics
    6.4.3 Speciality Clinics
    6.4.4 Homecare Settings
    6.4.5 Others
    6.5 Global Prostate Health Market by Region
    6.5.1 Market Overview
    6.5.2 North America
    6.5.3 Europe
    6.5.4 Asia Pacific
    6.5.5 Latin America
    6.5.6 Middle East and Africa
    7 North America Prostate Health Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Prostate Health Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Prostate Health Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Prostate Health Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Prostate Health Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 INDIA CDSCO
    16.1.4 JAPAN PMDA
    16.1.5 Others
    17 Supplier Landscape
    17.1 Abbott
    17.1.1 Financial Analysis
    17.1.2 Product Portfolio
    17.1.3 Demographic Reach and Achievements
    17.1.4 Mergers and Acquisition
    17.1.5 Certifications
    17.2 Novartis AG
    17.2.1 Financial Analysis
    17.2.2 Product Portfolio
    17.2.3 Demographic Reach and Achievements
    17.2.4 Mergers and Acquisition
    17.2.5 Certifications
    17.3 Teleflex
    17.3.1 Financial Analysis
    17.3.2 Product Portfolio
    17.3.3 Demographic Reach and Achievements
    17.3.4 Mergers and Acquisition
    17.3.5 Certifications
    17.4 AstraZeneca PLC
    17.4.1 Financial Analysis
    17.4.2 Product Portfolio
    17.4.3 Demographic Reach and Achievements
    17.4.4 Mergers and Acquisition
    17.4.5 Certifications
    17.5 Bayer AG
    17.5.1 Financial Analysis
    17.5.2 Product Portfolio
    17.5.3 Demographic Reach and Achievements
    17.5.4 Mergers and Acquisition
    17.5.5 Certifications
    17.6 Sanofi
    17.6.1 Financial Analysis
    17.6.2 Product Portfolio
    17.6.3 Demographic Reach and Achievements
    17.6.4 Mergers and Acquisition
    17.6.5 Certifications
    17.7 Pfizer
    17.7.1 Financial Analysis
    17.7.2 Product Portfolio
    17.7.3 Demographic Reach and Achievements
    17.7.4 Mergers and Acquisition
    17.7.5 Certifications
    17.8 Clovis Oncology
    17.8.1 Financial Analysis
    17.8.2 Product Portfolio
    17.8.3 Demographic Reach and Achievements
    17.8.4 Mergers and Acquisition
    17.8.5 Certifications
    17.9 Siemens Healthcare GmbH
    17.9.1 Financial Analysis
    17.9.2 Product Portfolio
    17.9.3 Demographic Reach and Achievements
    17.9.4 Mergers and Acquisition
    17.9.5 Certifications
    17.10 Elekta
    17.10.1 Financial Analysis
    17.10.2 Product Portfolio
    17.10.3 Demographic Reach and Achievements
    17.10.4 Mergers and Acquisition
    17.10.5 Certifications
    18 Global Prostate Health Market - Distribution Model (Additional Insight)
    18.1 Overview
    18.2 Potential Distributors
    18.3 Key Parameters for Distribution Partner Assessment
    19 Key Opinion Leaders (KOL) Insights (Additional Insight)
    20 Company Competitiveness Analysis (Additional Insight)
    20.1 Very Small Companies
    20.2 Small Companies
    20.3 Mid-Sized Companies
    20.4 Large Companies
    20.5 Very Large Companies
    21 Payment Methods (Additional Insight)
    21.1 Government Funded
    21.2 Private Insurance
    21.3 Out-of-Pocket
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.